Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 5 August 2026.
Announcements
1,961
Total raised
£9.3B
disclosed amounts
The seed round was backed by angel investors including Craig Pollard.
"If you understand the interests of your customers and the best methods to communicate with them through those interests, combined with a pinpoint understanding of exactly which partnerships your marketing budget will allow you to create and which of those opportunities mirror the beliefs that you as a business want to project to the world, then you have the foundations of successful sponsorship."
The investment was led by Argentem Creek Partners with backing from existing investors to fund market expansion and new product launches.
"We believe a payroll-centric approach is the key to integrating unbanked and underbanked workers in emerging markets into the financial system."
British Design Fund backed the Imperial College London spinout to support technology deployment and market growth.
"Palm trees provide a source of income for millions of farmers globally, significantly contributing to rural development by creating employment opportunities and improving infrastructure in remote areas. With our technology, we aim to help farmers generate the most sustainable yield from their plantations. This funding from British Design Fund will support deployment of our technology and growth in key markets."
The London-based cloud security firm has raised £3.9m in a seed round led by Accel to expand its engineering team and product offering.
"Our mission at Tracebit is to accelerate the mass adoption of threat deception for enterprises everywhere, and to reduce the mean time for detecting an intruder from months to minutes. Honeypots are one of the biggest deterrents to cyber attacks, but have been underused for too long due to their cost and complexity. This funding will help us bring threat deception to enterprises that haven’t felt able to leverage it before."
Marathon Venture Capital led the seed round to support team expansion and product development.
"Developing a drug remains an expensive and time-consuming process. Unlike other industries, product development in pharmaceuticals relies heavily on numerous experiments with minimal knowledge transfer from past products, driven by the expertise and know-how of scientists. We have witnessed first-hand the inefficiencies of traditional drug development, as well as the growing desire and business need to transform this field. Our vision for PolyModels Hub is to revolutionise how scientists, digital teams, and senior stakeholders collaborate to accelerate development efforts and bring breakthrough therapies to market faster than ever. With today’s advanced technology, supportive business context, and favourable regulatory framework, we believe now is the perfect time to realise this vision."
